These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1282958

  • 1. Endothelium-derived relaxing factor modulates renal interstitial cyclic GMP.
    Siragy HM.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S163-5. PubMed ID: 1282958
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide alters renal function and guanosine 3',5'-cyclic monophosphate.
    Siragy HM, Johns RA, Peach MJ, Carey RM.
    Hypertension; 1992 Jun; 19(6 Pt 2):775-9. PubMed ID: 1317356
    [Abstract] [Full Text] [Related]

  • 3. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses.
    Tolins JP, Palmer RM, Moncada S, Raij L.
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H655-62. PubMed ID: 2156453
    [Abstract] [Full Text] [Related]

  • 4. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function.
    Perrella MA, Hildebrand FL, Margulies KB, Burnett JC.
    Am J Physiol; 1991 Aug; 261(2 Pt 2):R323-8. PubMed ID: 1877690
    [Abstract] [Full Text] [Related]

  • 5. Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture.
    Marczin N, Ryan US, Catravas JD.
    Am J Physiol; 1992 Jul; 263(1 Pt 1):L113-21. PubMed ID: 1379001
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.
    Marsden PA, Ballermann BJ.
    J Exp Med; 1990 Dec 01; 172(6):1843-52. PubMed ID: 1979590
    [Abstract] [Full Text] [Related]

  • 7. Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs.
    Okumura M, Miura K, Yamashita Y, Yukimura T, Yamamoto K.
    J Pharmacol Exp Ther; 1992 Mar 01; 260(3):1262-7. PubMed ID: 1545391
    [Abstract] [Full Text] [Related]

  • 8. Renin-angiotensin system modulates renal bradykinin production.
    Siragy HM, Jaffa AA, Margolius HS, Carey RM.
    Am J Physiol; 1996 Oct 01; 271(4 Pt 2):R1090-5. PubMed ID: 8898005
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney.
    Scholz H, Kurtz A.
    J Clin Invest; 1993 Mar 01; 91(3):1088-94. PubMed ID: 8383697
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell.
    Johns RA, Peach MJ, Linden J, Tichotsky A.
    Circ Res; 1990 Oct 01; 67(4):979-85. PubMed ID: 2170053
    [Abstract] [Full Text] [Related]

  • 16. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
    Siragy HM, Jaffa AA, Margolius HS.
    Hypertension; 1997 Mar 01; 29(3):757-62. PubMed ID: 9052892
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation.
    Ishii K, Chang B, Kerwin JF, Huang ZJ, Murad F.
    Eur J Pharmacol; 1990 Feb 06; 176(2):219-23. PubMed ID: 2155799
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.